Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection

Cancer Gene Therapy
Xiang LiuJian-Ren Gu

Abstract

One of the major obstacles in current cancer gene therapy is the lack of a gene delivery system with high efficiency and targetability. In this paper, a nonviral gene delivery system GE7, which was designed to target EGF receptor (EGF R) overexpressed on the surface of cancer cel Is through an EGF R-binding oligopeptide (GE7), was used for in vivo gene therapy in a murine subcutaneous hepatoma model. It was demonstrated that the GE7 system could target the reporter gene beta-gal to EGF R-expressing hepatoma cells with high efficiency after in vitro transfection and in vivo peritumoral injection. To improve the therapeutic effect elicited by single gene transfer, human cyclin-dependent kinase inhibitor gene p21WAF-1 and murine cytokine gene GM-CSFwere used simultaneously in peritumoral injection of the GE7/DNA polyplex. The results showed that combined gene transfer of p21WAF-1 and GM-CSF could inhibit the growth of pre-established tumor more effectively and prolong the survival time of hepatoma-bearing mice more significantly than the transfer of a single gene. Apoptosis in the tumor tissues were found when injected with the p21WAF1-DNA polyplex. Prominent inflammatory infiltration was observed in the tumor tissue transfected w...Continue Reading

References

Apr 10, 1997·Human Gene Therapy·B J Foster, J A Kern
Sep 1, 1997·Nature Medicine·T WaldmanJ Williams
Mar 23, 2000·Journal of Hepatology·S S GhoshJ R Chowdhury
Apr 29, 2000·Current Opinion in Hematology·T L Warren, G J Weiner
Aug 30, 2008·Science in China. Series C, Life Sciences·P TianJ Gu

❮ Previous
Next ❯

Citations

Oct 28, 2004·Journal of Drug Targeting·Julia KloecknerErnst Wagner
Mar 1, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Klaas PoelstraLeonie Beljaars
Jun 30, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mohammadi KaouassDanuta Balicki
Jun 9, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Katharina von GersdorffErnst Wagner
Apr 24, 2016·Colloids and Surfaces. B, Biointerfaces·Keunsoo JeongSehoon Kim
Apr 15, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yong-Deok LeeSehoon Kim
Aug 29, 2003·Cancer Gene Therapy·René GérolamiClaude Bagnis
Jan 7, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shuxian SongYuhong Xu
Mar 7, 2007·Expert Review of Anticancer Therapy·John S Vorhies, John Nemunaitis
Mar 27, 2019·ACS Nano·Liangjun ZhaoM G Finn
Apr 16, 2015·Chemical Reviews·Ulrich Lächelt, Ernst Wagner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.